Surefire Medical, Inc.: Gene McGrevin Joins Surefire Medical's Board of Directors

   Surefire Medical, Inc.: Gene McGrevin Joins Surefire Medical's Board of
                                  Directors

PR Newswire

WESTMINSTER, Colo., Nov. 20, 2012

WESTMINSTER, Colo., Nov. 20, 2012 /PRNewswire/ --Surefire Medical, Inc., a
developer of innovative high-efficiency infusion systems for the
interventional radiology and interventional oncology markets, today announced
the appointment of Gene McGrevin to its Board of Directors.

"Gene McGrevin is an excellent medical device strategist with a very strong
background in sales, marketing and in running public companies. As Surefire
Medical transitions to full-scale commercialization in the U.S., Europe and
Asia, Gene's addition to the Surefire Board is both timely and a great gain
for the company," said Surefire Medical Board chairman Norman Weldon.

With 25 years of senior management positions in the medical industry at
companies including Johnson & Johnson and Kimberly-Clark Corporation, Mr.
McGrevin also was instrumental in the expansion and sale of several medical
startups. They include PetNet Pharmaceuticals (sold to Siemens), Microtek
Medical Holdings (sold to EcoLabs), and Medivance (sold to C.R. Bard).

"In my judgment Surefire Medical has the three key ingredients for success in
the marketplace," McGrevin said. "The company has innovative technology that
physicians are quickly adopting due to its proven clinical impact on patient
care. It has strong IP. And with higher embolization efficiency, Surefire
Medical's infusion devices are cost-effective as well as clinically relevant."

Mr. McGrevin also serves on the Boards of the Yerkes Primate Center, Real Time
Medical Data and HydroDynamics.

"We are delighted that Gene has joined the Board of Directors of Surefire
Medical," said Jim Chomas, Chief Executive Officer. "Gene's extensive
experience in strategic market development brings additional valuable
perspective to our Board. I look forward to his contributions as we advance
Surefire Medical's growth strategy."

Mr. McGrevin holds an MBA from the University of Pennsylvania's Wharton
School. He earned a BA in economics at the University of Pittsburgh.

About Surefire Medical

Surefire Medical, Inc., based in Westminster, Colo., was founded in 2009 to
develop a platform of innovative infusion systems for the interventional
radiology market. Surefire's infusion catheters precisely deliver embolic
agents through a novel expandable tip that collapses in forward flow and
dynamically expands to the vessel wall in reverse flow. The Surefire Infusion
System increases embolization efficiency, minimizes reflux and reduces damage
to healthy tissue. For more information, please visit
www.surefiremedical.com.

SOURCE Surefire Medical, Inc.

Website: http://www.surefiremedical.com
Contact: Edna Kaplan, KOGS Communication, +1-781-639-1910 (office),
+1-617-974-8659 (mobile), kaplan@kogspr.com
 
Press spacebar to pause and continue. Press esc to stop.